Skip to content

Frontlight ResearchEarly access

Trial site

Synexus Leipzig Clinical Research Centre (Site 1591)

Leipzig, Saxony 04103, GermanyNot linked to an institution yet

1running trial

Running trials

Active, not recruiting
Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes
NCT06008756· Phase 3· Merck Sharp & Dohme LLC· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Synexus Leipzig Clinical Research Centre (Site 1591): trial site – Frontlight Research